title: Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody.
authors.affiliation: Division of Hematology, Mayo Clinic, Rochester, Minnesota.
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
authors.affiliation: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Landau
authors.affiliation: Abramson Cancer Center, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania.
authors.forename: Brendan M
authors.initials: BM
authors.lastname: Weiss
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000075363:Immunoglobulin Light-chain Amyloidosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C000609646:birtamimab